SI
TEVA icon

SII Investments’s Teva Pharmaceuticals TEVA Stock Holding History

SII Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,739
Closed -$214K – 632
2017
Q1 		$214K Buy
6,739
+25
+0.4% +$853 0.01% 550
2016
Q4 		$245K Sell
6,714
-147
-2% -$5.87K 0.02% 500
2016
Q3 		$318K Sell
6,861
-939
-12% -$49K 0.02% 400
2016
Q2 		$394K Buy
7,800
+2,466
+46% +$131K 0.03% 371
2016
Q1 		$284K Buy
5,334
+829
+18% +$48.6K 0.03% 443
2015
Q4 		$297K Sell
4,505
-770
-15% -$47.6K 0.04% 348
2015
Q3 		$299K Buy
5,275
+938
+22% +$60.8K 0.03% 403
2015
Q2 		$257K Sell
4,337
-895
-17% -$55.2K 0.03% 428
2015
Q1 		$325K Sell
5,232
-150
-3% -$8.72K 0.04% 375
2014
Q4 		$311K Hold
5,382
– – 0.04% 360
2014
Q3 		$288K Buy
5,382
+150
+3% +$7.95K 0.04% 373
2014
Q2 		$275K Sell
5,232
-930
-15% -$47.5K 0.04% 367
2014
Q1 		$282K Hold
6,162
– – 0.05% 316
2013
Q4 		$247K Buy
6,162
+293
+5% +$11.5K 0.04% 354
2013
Q3 		$225K Sell
5,869
-1,063
-15% -$41.5K 0.05% 286
2013
Q2 		$274K Buy
+6,932
New +$270K 0.06% 295

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SII Investments's TEVA Position: Q2 2017 in Review

SII Investments sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 6,739 shares — an estimated $214K sold.

SII Investments first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $394K in Q2 2016. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • SII Investments reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • SII Investments sold 6,739 Teva Pharmaceuticals shares in Q2 2017, an estimated $214K.
  • SII Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • SII Investments's Teva Pharmaceuticals position peaked at $394K in Q2 2016.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on SII Investments's 13F filing for Q2 2017, filed 14 Aug 2017.